Gallardo, EMedina, JSánchez, J CViúdez, AGrande, EPorras, IRamón Y Cajal, TTrigo, JIglesias, LCapdevila, J2023-02-082023-02-082020-01-31http://hdl.handle.net/10668/15027Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/MultidisciplinarySystemic therapyThyroid cancerClinical Trials as TopicHumansMedical OncologyPractice Guidelines as TopicSocieties, MedicalThyroid Neoplasmsresearch article32006340open access10.1007/s12094-019-02284-81699-3055https://link.springer.com/content/pdf/10.1007/s12094-019-02284-8.pdf